Part of our team will be engaging in great scientific conversations at ESMO 2024 in Barcelona, from September 13-17. If you're attending, be sure to connect with @Matthias to learn about our latest advancements!

#ESMO24 #Science #Medicine #Oncology #Tacalyx

Our scientific team will present two posters at ENA 2024 in Barcelona (October 23-25)! 🎉 Will you be attending? If so, don’t miss the chance to meet @Wiebke and @Gustavo as they showcase our latest advancements and technologies!

Dr. Oren Moscovitz has been awarded €25,000 by the Max Planck Society for his promising research toward treatments and non-invasive diagnostics for cancer, which could potentially reduce overall cancer-related deaths. Moscovitz and his team exploit unique sugar patterns found on cancer cells and develop ultra-small antibodies from alpacas (known as nanobodies) that bind to these sugars.

https://www.mpikg.mpg.de/6834320/hermannneuhaus-prize-for-moscovitz?c=132305

Read the full press release here:

TCX-101, a novel antibody-drug conjugate targeting a tumor- associated carbohydrate antigen for the treatment of solid tumors

TCX-101, a novel antibody-drug conjugate targeting a tumor-associated carbohydrate antigen for the treatment of solid tumors

F. G. Gomes, F. Muraca, G. M. Schmidt Garcia Moreira, K. Rösch, M. Bräutigam, P. Sondermann, M. Ocker

Monday, 8th April, 1:30 - 5:00 PM (PST)
Session PO.ET02.01 - Antibody Drug Conjugates (Section 21)
Poster 3125/ 6

"This event is a fantastic opportunity for us to showcase our latest advancements and explore partnerships to further elevate our cancer research."

MATTHIAS OCKER Head of Experimental Medicine at Tacalyx

€ 500 K Health~Holland grant for new initiative against colorectal cancer. Read the full press release here:

Senior Pharma/Biotech and Life Science Expert joins Tacalyx´s Board of Directors as Chairman. Read the full press release here:

Read the full press release here: